Company intelligence / Profile preview

Diagenode

Liège, Belgium

Ownership: Private
Development stage: Other

Overview

Diagenode provides commercialized research solutions, including instruments and assays for epigenetics research, next-generation sequencing preparation, and diagnostics[1][5].

Modalities: DeviceReagent kitAntibodyAutomation instrumentsEpigenetic assay
Industry: Molecular Diagnostics

Partnerships

Nipd Genetics Limited (NIPD-KIT project)[3]Multiple academic research networks (FP6, FP7, H2020 European consortia)[3]

Beyond the preview

Go deeper on Diagenode.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagenode.

Explore the full profile